Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...

Critical congenital heart diseases, or CCHDs, are a group of life-threatening structural heart defects present at birth.

New Neonatal Study Adds to Body of Clinical Evidence Demonstrating Masimo SET ® Pulse Oximetry’s Unique Ability to Improve Care NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) provides ...

Pulse oximetry is a widely used monitoring method for measuring blood oxygen levels and pulse rate. In newborn babies, pulse oximetry can help clinicians conduct screening tests for lung or heart ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...

SIBEN, founded in 2004, is dedicated to improving newborn care throughout Latin America—where 15 babies die every hour, with 60% of those who die before their first birthday dying during the first 28 ...

For decades, standard clinical practice has called for examining the cardiovascular system as part of the routine newborn examination. Despite this practice, however, one in three infants with a ...